Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway
The Prostate · 2024-05 · 84 (7) · 666-681
DOI: 10.1002/pros.24683 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, online erschienen am 05.03.2024. Verfasst von Xiaoliang Hua und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Butyric Acid, Prostatitis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Science and Technology, China postdoctoral Science Foundation.
Abstract (Originalsprache)
Background
Chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) leads to severe discomfort in males and loss of sperm quality. Current therapeutic options have failed to achieve satisfactory results. Sodium butyrate (NaB) plays a beneficial role in reducing inflammation, increasing antioxidant capacities, and improving organ dysfunction; additionally NaB has good safety prospects and great potential for clinical application. The purpose of the current research was to study the effect of NaB on CP/CPPS and the underlying mechanisms using a mouse model of experimental autoimmune prostatitis (EAP) mice.
Methods
The EAP mouse model was successfully established by subcutaneously injecting a mixture of prostate antigen and complete Freund's adjuvant. Then, EAP mice received daily intraperitoneal injections of NaB (100, 200, or 400 mg/kg/day) for 16 days, from Days 26 to 42. We then explored anti‐inflammatory potential mechanisms of NaB by studying the effects of Nrf2 inhibitor ML385 and HO‐1 inhibitor zinc protoporphyrin on prostate inflammation and pelvic pain using this model. On Day 42, hematoxylin‐eosin staining and dihydroethidium staining were used to evaluate the histological changes and oxidative stress levels of prostate tissues. Chronic pelvic pain was assessed by applying Von Frey filaments to the lower abdomen. The levels of inflammation‐related cytokines, such as interleukin (IL)−1β, IL‐6, and tumor necrosis factor were detected by enzyme‐linked immunosorbent assay. The regulation of Nrf2/HO‐1 signaling pathway and the expression of NLRP3 inflammasome‐related protein in EAP mice were detected by western blot analysis assay.
Results
Compared with the EAP group, chronic pain development, histological manifestations, and cytokine levels showed that NaB reduced the severity of EAP. NaB treatment could inhibit NLRP3 inflammasome activation. Mechanism studies showed that NaB intervention could alleviate oxidative stress in EAP mice through Nrf2/HO‐1 signal pathway. Nrf2/HO‐1 pathway inhibitors can inhibit NaB ‐mediated oxidative stress. The inhibitory effect of NaB on the activation of NLRP3 inflammasome and anti‐inflammatory effect can also be blocked by Nrf2/HO‐1 pathway.
Conclusions
NaB treatment can alleviates prostatic inflammation and pelvic pain associated with EAP by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway. NaB has the potential as an effective agent in the treatment of EAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Peking University Fifth School of Clinical Medicine, Beijing, China.
- The Ministry of Education Key Laboratory of Laboratory Medical Diagnostics, The College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
ORCID-Profile: Xiaoliang Hua, Jiong Zhang, Li Zhang, Chaozhao Liang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing Science and Technology
- China postdoctoral Science Foundation
Zitieren
APA
Hua, X., Zhang, J., Chen, J., Feng, R., Zhang, L., Chen, X., Jiang, Q., Yang, C., & Liang, C. (2024). Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway. The Prostate, 84(7), 666-681. https://doi.org/10.1002/pros.24683
Vancouver
Hua X, Zhang J, Chen J, Feng R, Zhang L, Chen X, et al. Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway. The Prostate. 2024;84(7):666-681. doi:10.1002/pros.24683
BibTeX
@article{Hua2024,
author = {Hua, Xiaoliang and Zhang, Jiong and Chen, Juan and Feng, Rui and Zhang, Li and Chen, Xianguo and Jiang, Qing and Yang, Cheng and Liang, Chaozhao},
title = {Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway},
journal = {The Prostate},
year = {2024},
volume = {84},
number = {7},
pages = {666--681},
doi = {10.1002/pros.24683}
}
EUVIMED